Exhibit 99.1
![]() | Nanophase Technologies Corporation 1319 Marquette Drive Romeoville, IL 60446 |
COMPANY CONTACT:
Nancy Baldwin
Investor Relations
630-771-6708
Nanophase Reports Third Quarter 2009 Financial Results with
Improved Margins and Reduced Operating Losses
Romeoville, IL,– October 28, 2009 –Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and advanced nanoengineered products, today reported financial results for its third quarter ended September 30, 2009.
Third Quarter
Revenue for the third quarter of 2009 was $1.7 million, compared to $2.1 million for the same period in 2008.
“While economic conditions have affected revenue in 2009, we are pleased to see a revenue increase on a quarter-to-quarter basis,” commented Nanophase CEO and President Jess Jankowski. “It is difficult to predict when the economy will right itself, yet the overall disposition of the financial community and industry leaders seems more positive than it has been for some time.
“We are beginning to see the benefits of our new, leaner business strategy as gross margins (as a percentage of revenue) increased by 93 percent over the comparable third quarter in 2008, a positive indication that we are heading in the right direction,” added Jankowski.
The net loss for the quarter was $0.9 million, or a loss of $0.04 per share, compared to a net loss of $2.8 million, or a loss of $0.13 per share, for the third quarter of 2008. Of the $2.8 million loss in the third quarter of 2008, $1.2 million were operating losses and $1.6 million were attributed to severance charges.
Jankowski continued, “We are seeing positive results from our structural efficiencies. While revenue was down from the prior year, the net outcome was a $0.3 million improvement. Our strategy is just beginning to demonstrate the results we expect to see in the coming quarters.
“Our customers remain concerned about inventory levels as economic recovery remains tenuous. We expect revenue in the coming quarter to be inline with the previous three quarters, base-lining our expectations at around $1.2M. We feel confident that our development of new customers and markets will position the company for growth in 2010 even if the overall economy remains sluggish.”
- more -
Nanophase Reports Third Quarter 2009 Financial Results With Improved Margins and Reduced Operating Losses
Page 2
Jankowski will be discussing the company’s third quarter performance and future prospects during today’s conference call. Shareholders and members of the investing community are encouraged to participate.
Third Quarter Financial Results Conference Call
Nanophase has scheduled its quarterly conference call for October 28, 2009, at 4:00 p.m. CDT (5:00 p.m. EDT), which will be hosted by Jess Jankowski, president and CEO. To participate in the call you may dial toll-free 800-344-8034, or 785-830-1990 for international callers. The conference call identification is 7NANOPHASE. The call may also be accessed through the company’s website,www.nanophase.com, by clicking on the link under News Center and Calendar of Events. If you are unable to attend, a replay will be available through November 4, 2009, by dialing toll-free 800-283-4593, or 402-220-0872, or by logging onto the company’s website and following the directions above.
Use of Non-GAAP Financial Information
Nanophase believes that the presentation of results excluding certain items, including severance charges and non-cash equity compensation charges, provides meaningful supplemental information to both management and investors, facilitating the evaluation of performance across reporting periods. The Company uses these non-GAAP measures for internal planning and reporting purposes. These non-GAAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. The presentation of this additional information is not meant to be considered in isolation or as a substitute for net income or net income per share prepared in accordance with generally accepted accounting principles.
About Nanophase Technologies
Nanophase Technologies Corporation (NANX),www.nanophase.com, is a leader in nanomaterials technologies and provides nanoengineered products and solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2000 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media.
Forward-Looking Statements
This press release contains words such as “expects,” “shall,” “will,” , “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s nanocrystalline materials; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; and other factors described in the Company’s Form 10-K filed March 25, 2009. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.
Tables follow
NANOPHASE TECHNOLOGIES CORPORATION
BALANCE SHEETS
(Unaudited)
ASSETS | September 30, 2009 | December 31, 2008 | ||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 1,141,253 | $ | 723,069 | ||||
Investments | 1,879,168 | 6,908,888 | ||||||
Trade accounts receivable, less allowance for doubtful accounts of $9,000 on September 30, 2009 and December 31, 2008 | 784,738 | 1,092,125 | ||||||
Other receivable | — | 7,749 | ||||||
Inventories, net | 1,215,858 | 1,154,207 | ||||||
Prepaid expenses and other current assets | 352,168 | 482,452 | ||||||
Total current assets | 5,373,185 | 10,368,490 | ||||||
Investments | 5,340,000 | 5,340,000 | ||||||
Equipment and leasehold improvements, net | 5,824,031 | 6,651,842 | ||||||
Other assets, net | 40,087 | 39,765 | ||||||
$ | 16,577,303 | $ | 22,400,097 | |||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Current portion of capital lease obligations | 8,277 | 22,211 | ||||||
Current portion of deferred other revenue | — | 74,243 | ||||||
Current portion of long term debt, less current maturities and debt discount | — | 1,570,346 | ||||||
Accounts payable | 381,103 | 356,853 | ||||||
Accrued expenses | 1,359,984 | 1,493,262 | ||||||
Accrued severance | 179,403 | 541,014 | ||||||
Total current liabilities | 1,928,767 | 4,057,929 | ||||||
Long-term portion of capital lease obligations | 2,940 | 9,219 | ||||||
2,940 | 9,219 | |||||||
Contingent liabilities: | — | — | ||||||
Stockholders’ equity: | ||||||||
Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding | — | — | ||||||
Common stock, $.01 par value, 30,000,000 shares authorized; 21,204,162 and 21,188,912 shares issued and outstanding on September 30, 2009 and December 31, 2008, respectively | 212,042 | 211,889 | ||||||
Additional paid-in capital | 92,132,943 | 91,597,529 | ||||||
Accumulated deficit | (77,699,389 | ) | (73,476,469 | ) | ||||
Total stockholders’ equity | 14,645,596 | 18,332,949 | ||||||
$ | 16,577,303 | $ | 22,400,097 | |||||
NANOPHASE TECHNOLOGIES CORPORATION
STATEMENTS OF OPERATIONS
(Unaudited)
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
2009 | As Adjusted 2008 | 2009 | As Adjusted 2008 | |||||||||||||
Revenue: | ||||||||||||||||
Product revenue, net | $ | 1,633,653 | $ | 1,967,061 | $ | 4,431,199 | $ | 7,721,408 | ||||||||
Other revenue | 87,828 | 111,906 | 306,103 | 356,072 | ||||||||||||
Total revenue | 1,721,481 | 2,078,967 | 4,737,302 | 8,077,480 | ||||||||||||
Operating expense: | ||||||||||||||||
Cost of revenue | 1,264,058 | 1,789,049 | 4,009,345 | 5,625,533 | ||||||||||||
Gross Profit | 457,423 | 289,918 | 727,957 | 2,451,947 | ||||||||||||
Research and development expense | 433,593 | 443,241 | 1,218,712 | 1,298,175 | ||||||||||||
Selling, general and administrative expense | 913,456 | 1,113,156 | 2,964,966 | 4,217,542 | ||||||||||||
Severance charges | — | 1,578,859 | 794,069 | 1,578,859 | ||||||||||||
Loss from operations | (889,626 | ) | (2,845,338 | ) | (4,249,790 | ) | (4,642,629 | ) | ||||||||
Interest income | 15,990 | 82,301 | 74,284 | 330,311 | ||||||||||||
Interest expense | (2,076 | ) | (29,410 | ) | (35,362 | ) | (100,969 | ) | ||||||||
Other, net | — | (8,651 | ) | (12,052 | ) | (8,494 | ) | |||||||||
Loss before provision for income taxes | (875,712 | ) | (2,801,098 | ) | (4,222,920 | ) | (4,421,781 | ) | ||||||||
Provision for income taxes | — | — | — | — | ||||||||||||
Net loss | $ | (875,712 | ) | $ | (2,801,098 | ) | $ | (4,222,920 | ) | $ | (4,421,781 | ) | ||||
Net loss per share—basic and diluted | $ | (0.04 | ) | $ | (0.13 | ) | $ | (0.20 | ) | $ | (0.21 | ) | ||||
Weighted average number of common shares outstanding | 21,204,162 | 21,150,568 | 21,201,927 | 21,129,369 | ||||||||||||
NANOPHASE TECHNOLOGIES CORPORATION
STATEMENTS OF OPERATIONS—EXPANDED SCHEDULE
(Unaudited)
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
2009 | As Adjusted 2008 | 2009 | As Adjusted 2008 | |||||||||||||
Revenue: | ||||||||||||||||
Product revenue, net | $ | 1,633,653 | $ | 1,967,061 | $ | 4,431,199 | $ | 7,721,408 | ||||||||
Other revenue | 87,828 | 111,906 | 306,103 | 356,072 | ||||||||||||
Total revenue | 1,721,481 | 2,078,967 | 4,737,302 | 8,077,480 | ||||||||||||
Operating expense: | ||||||||||||||||
Cost of revenue detail: | ||||||||||||||||
Depreciation | 227,092 | 252,172 | 713,160 | 730,792 | ||||||||||||
Non-Cash equity compensation | 6,699 | 21,949 | 33,115 | 58,885 | ||||||||||||
Other costs of revenue | 1,030,267 | 1,514,928 | 3,263,070 | 4,835,856 | ||||||||||||
Cost of revenue | 1,264,058 | 1,789,049 | 4,009,345 | 5,625,533 | ||||||||||||
Gross profit | 457,423 | 289,918 | 727,957 | 2,451,947 | ||||||||||||
Research and development expense detail: | ||||||||||||||||
Depreciation | 57,271 | 59,886 | 171,541 | 177,661 | ||||||||||||
Non-Cash equity compensation | 28,818 | 40,031 | 76,840 | 109,344 | ||||||||||||
Other research and development expense | 347,504 | 343,324 | 970,331 | 1,011,170 | ||||||||||||
Research and development expense | 433,593 | 443,241 | 1,218,712 | 1,298,175 | ||||||||||||
Selling, general and administrative expense detail: | ||||||||||||||||
Depreciation and amortization | 19,352 | 15,759 | 59,079 | 45,464 | ||||||||||||
Non-Cash equity compensation | 72,138 | 96,299 | 228,571 | 422,931 | ||||||||||||
Trademark abandonment charge | — | 37,214 | — | 37,214 | ||||||||||||
Other selling, general and administrative expense | 821,966 | 963,884 | 2,677,316 | 3,711,933 | ||||||||||||
Selling, general and administrative expense | 913,456 | 1,113,156 | 2,964,966 | 4,217,542 | ||||||||||||
Severance charges | — | 1,578,859 | 794,069 | 1,578,859 | ||||||||||||
Loss from operations | (889,626 | ) | (2,845,338 | ) | (4,249,790 | ) | (4,642,629 | ) | ||||||||
Interest income | 15,990 | 82,301 | 74,284 | 330,311 | ||||||||||||
Interest expense | (2,076 | ) | (29,410 | ) | (35,362 | ) | (100,969 | ) | ||||||||
Other, net | — | (8,651 | ) | (12,052 | ) | (8,494 | ) | |||||||||
Loss before provision for income taxes | (875,712 | ) | (2,801,098 | ) | (4,222,920 | ) | (4,421,781 | ) | ||||||||
Provision for income taxes | — | — | — | — | ||||||||||||
Net loss | $ | (875,712 | ) | $ | (2,801,098 | ) | $ | (4,222,920 | ) | $ | (4,421,781 | ) | ||||
Non-GAAP Disclosure (see note regarding Non-GAAP disclosures): | ||||||||||||||||
Addback Interest, net | (13,914 | ) | (52,891 | ) | (38,922 | ) | (229,342 | ) | ||||||||
Addback Other Deferred Revenue | (10,608 | ) | (31,818 | ) | (74,243 | ) | (95,454 | ) | ||||||||
Addback Depreciation/Amortization | 303,715 | 327,817 | 943,780 | 953,917 | ||||||||||||
Addback Abandonment of Trademarks | — | 37,214 | — | 37,214 | ||||||||||||
Addback Severance Charge | — | 1,578,859 | 794,069 | 1,578,859 | ||||||||||||
Addback Non-Cash Equity Compensation | 107,655 | 158,279 | 338,526 | 591,160 | ||||||||||||
Adjusted EBITDA | $ | (488,864 | ) | $ | (783,638 | ) | $ | (2,259,710 | ) | $ | (1,585,427 | ) | ||||